Driehaus Capital Management’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

Driehaus Capital Management’s Portfolio KBIO Stock Details KBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-11,695	Closed	-$530K	–	586
2013 Q2	$530K	Buy	+11,695	New	+$530K	0.02%	382

Other funds holding KBIO

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LBH

Lehman Brothers Holdings New York $794K AUM 28.79% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

WSA

Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Driehaus Capital Management's KBIO Position: Q3 2013 in Review

Driehaus Capital Management sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q3 2013, closing a stake of 11,695 shares — an estimated $530K sold.

Driehaus Capital Management first reported a position in KBIO in Q2 2013 and held it in 1 quarter. The position peaked at $530K in Q2 2013. 50 funds tracked by Wall St. Rank hold KBIO as of Q3 2013.

Driehaus Capital Management reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q3 2013 after selling out during the quarter.
Driehaus Capital Management sold 11,695 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q3 2013, an estimated $530K.
Driehaus Capital Management first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q2 2013 and held it in 1 quarter.
Driehaus Capital Management's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $530K in Q2 2013.
50 funds tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q3 2013.

Based on Driehaus Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.